You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Ommaya Artificial Organ for Islet Transplantation

    SBC: Cyborgan, Inc.            Topic: N/A

    The research seeks to establish the feasibility of a microencapsulation device containing isletcells for the treatment of insulin dependent diabetes. The device is a direct application of the spinal fluidflow driven artificial organ invented by the P.I. (U.S. Patent No. 5,222,982). Preliminary experimentsin vitro and in vivo (canine model) indicate that xenograft islet cells are immune protected w ...

    SBIR Phase I 1994 Department of Health and Human Services
  2. Methods Analyzing Categorical Data

    SBC: CYTEL SOFTWARE CORPORATION            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services
  3. Sample-Size Software for Ordered Categorical Data

    SBC: CYTEL SOFTWARE CORPORATION            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services
  4. Isolation of Human Hematopoietic Stem Cells

    SBC: Cytomed, Inc.            Topic: N/A

    We aim to produce and characterize polyclonal antisera to the newly discovered 9804 antigenfor assessing the potential value of this molecule in isolating human hematopoietic stem cells (HSC) .Important for this characterization is an understanding of the gene (or gene family) that encodes the9804 protein; therefore, the project also seeks to define the nature of the 9804 cDNA in human bonemarrow ...

    SBIR Phase I 1994 Department of Health and Human Services
  5. Cloning Hematopoietic Genes by MRNA Differential Display

    SBC: Cytomed, Inc.            Topic: N/A

    Advances in the use of hematopoietic stem cells for transplantation and gene therapy haveincreased the urgency for a better knowledge of the molecular control of their development andproliferation. An understanding of the molecular processes involved in the earliest stages of stem celldevelopment, currently poorly understood, would provide very useful guide to the selection, expansionand ex-vivo m ...

    SBIR Phase I 1994 Department of Health and Human Services
  6. Automated Pap Test Screening for Quality Control

    SBC: CYTYC Corporation            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services
  7. HOUSEHOLD EXPOSURES TO HAZARDOUS SUBSTANCES

    SBC: DELIMA ASSOCIATES            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services
  8. Positional Device for Essential Elevation of Upper Tors

    SBC: Design Able, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services
  9. Pediatric Conscious Sedation Device

    SBC: Design Continuum            Topic: N/A

    We will develop and manufacture a prototype of the "Pediatric Sedation Device" in Phase I. Thisdevice will be utilized for conscious sedation in pediatric patients undergoing painful procedures ordiagnostic evaluations. In Phase II, clinical trials will be conducted. Nitrous Oxide and Oxygen will bedispensed in variable amounts, not to exceed 50% nitrous oxide and 50% oxygen. A dispensed invariabl ...

    SBIR Phase I 1994 Department of Health and Human Services
  10. Hepatocellular Therapy for Hypercholesterolemia

    SBC: Diacrin, Inc.            Topic: N/A

    Familial hypercholesterolemia (FH) is a genetic disease resulting from mutations in the LKLrecptor. Markedly elevated serum cholesterol levels lead to heart disease in FH, and the availablepharmacological therapy is often not adequate to reduce cholesterol to safe levels. Hepatocytetransplantation has the capacity to be used as a therapy for hypercholesterolemia, but the problem ofrejection of for ...

    SBIR Phase I 1994 Department of Health and Human Services
US Flag An Official Website of the United States Government